Top

LATEST PUBLICATIONS



New article explains the pros and cons of nasal vaccines

June 10, 2021

Category: Industry, Vaccines

Vaccines are mostly synonymous with needles, an efficient and effective way to provide immunity to myriad infections. As COVID-19 vaccination efforts roll out across the U.S. and the world, some experts believe that a vaccine administered through the nose could […]


FDA approves Alkermes’ Lybalvi for schizophrenia and bipolar I disorder

June 2, 2021

Category: FDA, Regulations

Lybalvi (olanzapine and samidorphan) has been authorised as maintenance monotherapy of adults with schizophrenia or bipolar I disorder, for the acute treatment of manic or mixed episodes and as monotherapy or an adjunct to lithium or valproate. In clinical trials, […]


FDA restricts use of Intercept drug due to liver injury risk

May 27, 2021

Category: FDA, Regulations

The FDA action won’t have an immediate impact on sales of Ocaliva because the majority of patients taking the drug don’t have advanced cirrhosis, according to Intercept. The company prepared investors for the move earlier this month when it released […]


Industry, Vaccines

NCCN experts provide new guidance on COVID-19 vaccines for cancer patients

June 11, 2021

Via: Medical News

The National Comprehensive Cancer Network (NCCN) today announced the publication of new guidance on COVID-19 vaccines for people with cancer, intended to clear up confusion for patients and caregivers. The new four-page patient guide is based on the latest expert […]


FDA, Industry, News, Vaccines

Ocugen gets a black eye as FDA denies emergency OK for COVID jab

June 11, 2021

Via: Pharmaphorum

That will hold back the biotech’s Covaxin shot by several months, and the delay put pressure on Ocugen’s share price, which fell more than 25% after the announcement. The Philadelphia-based company said it had taken the decision to go down […]


Industry, News, Vaccines

Study links AstraZeneca COVID-19 shot to bleeding disorder ITP

June 10, 2021

Via: Pharmaphorum

The scientists examined real-world public health data from all individuals in Scotland who received either the AZ or Pfizer/BioNTech vaccines up until 14 April and found a possible association between the AZ shot and an autoimmune disorder called idiopathic thrombocytopenic […]


Mergers and Acquisitions, News

Merck signs $1.2bn supply deal with US government for Molnupiravir

June 9, 2021

Via: PMLiVE

The treatment, being developed by Merck in collaboration with Ridgeback Biotherapeutics, is currently being evaluated in a phase 3 clinical trial. The trial, know as the MOVe-OUT study, is evaluating molnupiravir in the treatment of non-hospitalised patients with laboratory-confirmed COVID-19 […]


Cell and Gene Therapy, Industry

Beigene expands into cancer cell therapy with Shoreline pact

June 9, 2021

Via: Biopharma Dive

Beigene has quickly become a force in cancer drug development, earning approvals in the U.S. and China for its targeted therapy Brukinsa and immunotherapy tislelizumab. The biotech is developing a slate of small molecule and antibody drugs aimed at several […]